AOK RHEINLANDPFALZSAARLAND DIE GESUNDHEITSKASSE
A United Kingdom buyer, with 13 published contracts, worth £335k, most recently 3 months ago.
Top 2 suppliers won 100% of awarded value — £153k of £153k across 10 awards.
This contract opportunity involves the establishment of non-exclusive discount agreements for the pharmaceutical product Denosumab, marketed as Xgeva, in accordance with German social law. The contracts will be valid from July 1, 2025, to June 30, 2027, and suppliers can enter into agreements at any
This contract opportunity involves the establishment of non-exclusive discount contracts for the pharmaceutical product Somatropin, classified under ATC code H01AC01. The contracts will be valid from July 1, 2025, to June 30, 2027, and suppliers can enter into contracts at any time during this perio
